NCGC00135472, CAS [[862811-76-5]]

Produktübersicht

• Artikelname: NCGC00135472, CAS [[862811-76-5]]
• Artikelnummer: TGM-T33613
• Hersteller Artikelnummer: T33613
• Alternativnummer: TGM-T33613-1MG,TGM-T33613-5MG,TGM-T33613-10MG,TGM-T33613-25MG,TGM-T33613-50MG,TGM-T33613-100MG,TGM-T33613-500MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: NCGC 00135472 , C2A , DRV1 (GPR32) agonist C2A , NCGC-00135472

Produktbeschreibung

NCGC00135472 (DRV1 (GPR32) agonist C2A) is a human Resolvin DI receptor DRV1 agonist with pro-catabolic properties that activates the human soluble protein D1 receptor DRV1/GPR32 receptor in beta-blocker and cAMP assays with EC50s of 0.37 uM and 0.05 uM, respectively.NCGC00135472 induces in cells overexpressing recombinant DRV1 rapid impedance changes that stimulate phagocytosis of serum-treated zymoglycans.

Produkteigenschaften

• Molekulargewicht: 364.35
• Reinheit: 99.54%
• CAS Nummer: [862811-76-5]
• Formel: C20H14F2N4O
• Target-Kategorie: Others|||Arrestin

Bilder

T33613